|
Aug. 20, 2021 |
|
|
Jan. 27, 2025 |
|
|
jRCT2031210266 |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer |
|
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer |
Ichioka Shigeru |
||
Saitama Medical University Hospital |
||
38 Morohongo Moroyama-machi, Iruma-gun |
||
+81-492-76-1299 |
||
ichioka2006@yahoo.co.jp |
||
Tomioka Hideki |
||
FunPep Co., Ltd. |
||
Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka |
||
+81-6-6369-7957 |
||
htomioka@funpep.co.jp |
Complete |
Aug. 02, 2021 |
||
| 120 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
placebo control |
||
parallel assignment |
||
treatment purpose |
||
Patients must have a wound requiring wound bed preparation in advance of planned surgical closure (including suturing, grafts or flaps) |
||
Presence of untreated ulcer infection (redness, swelling, pus, foul odor, fever) |
||
| 18age old over | ||
| 85age old not | ||
Both |
||
skin ulcer |
||
SR-0379 or placebo spray |
||
The days to simple surgical intervention (ncluding suturing, grafts or flaps) |
||
| FunPep Co., Ltd. |
| Saitama Medical University Hospital Clinical Trial | |
| 38 Morohongo Moroyama-machi, Iruma-gun, Saitama | |
+81-49-276-1454 |
|
| tikens@saitama-med.ac.jp | |
| Approval | |
July. 01, 2021 |
No |
none |